In a follow-up study, the authors developed and characterized an 111In-cetuximab-F(ab’)2 tracer using the same model and found that 111In-cetuximab-F(ab’)2 displayed higher tumor-to-blood ratios making it more suitable for EGFR visualization (137, 138). The gene discussed is EGFR; the disease is neoplasm.